- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
SMAD3 Antibody recognizes SMAD3, a receptor-regulated intracellular signaling protein that functions as a central mediator of transforming growth factor beta signaling. Encoded by the SMAD3 gene, this transcriptional regulator is activated following phosphorylation by transforming growth factor beta receptors, allowing it to associate with SMAD4 and translocate to the nucleus where it regulates the expression of numerous target genes. Through these activities, SMAD3 influences cell proliferation, differentiation, extracellular matrix production, immune regulation, apoptosis, and tissue repair. Because of its central position within this highly conserved signaling pathway, SMAD3 has become one of the most extensively studied mediators of transforming growth factor beta responses. NSJ Bioreagents offers this SMAD3 Antibody, clone PCRP-SMAD3-1A2, as a Protein Microarray Validated mouse monoclonal antibody for reliable research applications.
Transforming growth factor beta signaling regulates numerous developmental and homeostatic processes throughout the body. Following ligand binding, activated receptors phosphorylate receptor-regulated SMAD proteins, including SMAD3, which subsequently form transcriptionally active complexes that coordinate gene expression programs in conjunction with additional nuclear cofactors. Depending on cellular context, SMAD3 can promote or suppress specific transcriptional responses, contributing to tightly regulated control of cellular growth, differentiation, inflammation, and extracellular matrix remodeling. Researchers commonly employ SMAD3 Antibody to investigate protein localization, expression, and signaling activity in studies of cell biology, developmental biology, immunology, fibrosis, and cancer.
Altered SMAD3 activity has been implicated in numerous pathological conditions, including tissue fibrosis, cardiovascular disease, inflammatory disorders, and tumor progression. As a principal downstream effector of transforming growth factor beta receptors, SMAD3 is widely investigated for its role in epithelial-to-mesenchymal transition, wound healing, immune cell regulation, and connective tissue remodeling. These diverse biological functions continue to make SMAD3 an important molecular target in both basic and translational research. Clone PCRP-SMAD3-1A2 has also been Protein Microarray Validated, demonstrating high specificity and providing researchers with additional confidence when evaluating SMAD3 expression across experimental systems.
SMAD3 Antibody supports the investigation of transforming growth factor beta signaling through the detection and characterization of this key intracellular signaling mediator. Protein Microarray Validated clone PCRP-SMAD3-1A2 provides a valuable tool for studies of signal transduction, transcriptional regulation, fibrosis, development, and disease-associated changes involving TGF-beta Signaling Protein SMAD3.
Explore our Signal Transduction Antibodies page to discover additional antibodies for studying TGF-beta signaling, kinase pathways, transcriptional regulators, and other intracellular signaling proteins.
Optimal dilution of the SMAD3 Antibody / TGF-beta Signaling Protein Antibody should be determined by the researcher.
Recombinant full-length human SMAD3 protein was used as the immunogen for the SMAD3 antibody.
Aliquot the SMAD3 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Mothers Against Decapentaplegic Homolog 3 antibody, MADH3 antibody, Mothers Against DPP Homolog 3 antibody, SMAD Family Member 3 antibody, TGF-beta Signal Transducer SMAD3 antibody, Receptor-Regulated SMAD3 antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.